BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 29453200)

  • 1. Risk of Cardiovascular Disease and Death in Individuals With Prediabetes Defined by Different Criteria: The Whitehall II Study.
    Vistisen D; Witte DR; Brunner EJ; Kivimäki M; Tabák A; Jørgensen ME; Færch K
    Diabetes Care; 2018 Apr; 41(4):899-906. PubMed ID: 29453200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversion from prediabetes to normoglycaemia and risk of cardiovascular disease and mortality: the Whitehall II cohort study.
    Vistisen D; Kivimäki M; Perreault L; Hulman A; Witte DR; Brunner EJ; Tabák A; Jørgensen ME; Færch K
    Diabetologia; 2019 Aug; 62(8):1385-1390. PubMed ID: 31123789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic effect of prediabetes defined by different criteria in patients with stable coronary artery disease: a prospective cohort study in Asia.
    Cui K; Yin D; Song W; Wang H; Zhu C; Feng L; Li J; Jia L; Lu Y; Zhang R; Shi B; Song Y; Fu R; Dou K
    Eur J Prev Cardiol; 2023 Oct; 30(14):1418-1426. PubMed ID: 36987575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative prognostic performance of definitions of prediabetes: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study.
    Warren B; Pankow JS; Matsushita K; Punjabi NM; Daya NR; Grams M; Woodward M; Selvin E
    Lancet Diabetes Endocrinol; 2017 Jan; 5(1):34-42. PubMed ID: 27863979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline Characteristics of the Vitamin D and Type 2 Diabetes (D2d) Study: A Contemporary Prediabetes Cohort That Will Inform Diabetes Prevention Efforts.
    LeBlanc ES; Pratley RE; Dawson-Hughes B; Staten MA; Sheehan PR; Lewis MR; Peters A; Kim SH; Chatterjee R; Aroda VR; Chadha C; Neff LM; Brodsky IG; Rosen C; Desouza CV; Foreyt JP; Hsia DS; Johnson KC; Raskin P; Kashyap SR; O'Neil P; Phillips LS; Rasouli N; Liao EP; Robbins DC; Pittas AG;
    Diabetes Care; 2018 Aug; 41(8):1590-1599. PubMed ID: 29941495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediabetes, Diabetes, and the Risk of All-Cause and Cause-Specific Mortality in a Japanese Working Population: Japan Epidemiology Collaboration on Occupational Health Study.
    Islam Z; Akter S; Inoue Y; Hu H; Kuwahara K; Nakagawa T; Honda T; Yamamoto S; Okazaki H; Miyamoto T; Ogasawara T; Sasaki N; Uehara A; Yamamoto M; Kochi T; Eguchi M; Shirasaka T; Shimizu M; Nagahama S; Hori A; Imai T; Nishihara A; Tomita K; Sone T; Konishi M; Kabe I; Mizoue T; Dohi S;
    Diabetes Care; 2021 Mar; 44(3):757-764. PubMed ID: 33441421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of prediabetes, defined by fasting glucose, HbA1c only, or combined criteria, with the risk of cardiovascular disease in Koreans.
    Kim HK; Lee JB; Kim SH; Jo MW; Kim EH; Hwang JY; Bae SJ; Jung CH; Lee WJ; Park JY; Park GM; Kim YH; Choe J
    J Diabetes; 2016 Sep; 8(5):657-66. PubMed ID: 26355268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between fasting plasma glucose and glycated hemoglobin in the prediabetes range and future development of hypertension.
    Geva M; Shlomai G; Berkovich A; Maor E; Leibowitz A; Tenenbaum A; Grossman E
    Cardiovasc Diabetol; 2019 Apr; 18(1):53. PubMed ID: 31029146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiometabolic risk factors in Thai individuals with prediabetes treated in a high-risk, prevention clinic: Unexpected relationship between high-density lipoprotein cholesterol and glycemia in men.
    Srivanichakorn W; Godsland IF; Washirasaksiri C; Phisalprapa P; Charatcharoenwitthaya P; Pramyothin P; Sitasuwan T; Preechasuk L; Elkeles R; Alberti KGM; Johnston DG; Oliver NS
    J Diabetes Investig; 2019 May; 10(3):771-779. PubMed ID: 30387292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detecting prediabetes among Hispanics/Latinos from diverse heritage groups: Does the test matter? Findings from the Hispanic Community Health Study/Study of Latinos.
    Avilés-Santa ML; Pérez CM; Schneiderman N; Savage PJ; Kaplan RC; Teng Y; Suárez EL; Cai J; Giachello AL; Talavera GA; Cowie CC
    Prev Med; 2017 Feb; 95():110-118. PubMed ID: 27956225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermediate hyperglycaemia to predict progression to type 2 diabetes (ELSA-Brasil): an occupational cohort study in Brazil.
    Schmidt MI; Bracco PA; Yudkin JS; Bensenor IM; Griep RH; Barreto SM; Castilhos CD; Duncan BB
    Lancet Diabetes Endocrinol; 2019 Apr; 7(4):267-277. PubMed ID: 30803929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiometabolic Risk Profiles in Patients With Impaired Fasting Glucose and/or Hemoglobin A1c 5.7% to 6.4%: Evidence for a Gradient According to Diagnostic Criteria: The PREDAPS Study.
    Giráldez-García C; Sangrós FJ; Díaz-Redondo A; Franch-Nadal J; Serrano R; Díez J; Buil-Cosiales P; García-Soidán FJ; Artola S; Ezkurra P; Carrillo L; Millaruelo JM; Seguí M; Martínez-Candela J; Muñoz P; Goday A; Regidor E;
    Medicine (Baltimore); 2015 Nov; 94(44):e1935. PubMed ID: 26554799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of the Hemoglobin Glycation Index on the Diagnosis of Prediabetes and Diabetes.
    Hsia DS; Rasouli N; Pittas AG; Lary CW; Peters A; Lewis MR; Kashyap SR; Johnson KC; LeBlanc ES; Phillips LS; Hempe JM; Desouza CV;
    J Clin Endocrinol Metab; 2020 Mar; 105(3):e130-8. PubMed ID: 31965161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.
    Kuzuya T; Nakagawa S; Satoh J; Kanazawa Y; Iwamoto Y; Kobayashi M; Nanjo K; Sasaki A; Seino Y; Ito C; Shima K; Nonaka K; Kadowaki T;
    Diabetes Res Clin Pract; 2002 Jan; 55(1):65-85. PubMed ID: 11755481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HbA1c-based rather than fasting plasma glucose-based definitions of prediabetes identifies high-risk patients with angiographic coronary intermediate lesions: a prospective cohort study.
    Song C; Yuan S; Cui K; Cai Z; Zhang R; He J; Qiao Z; Bian X; Wu S; Wang H; Shi B; Lin Z; Fu R; Wang C; Liu Q; Jia L; Dong Q; Dou K
    Cardiovasc Diabetol; 2023 Mar; 22(1):68. PubMed ID: 36966299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediabetes defined by the International Expert Committee as a risk for development of glomerular hyperfiltration.
    Kawata I; Koshi T; Hirabayashi K; Koike H; Sato Y; Yamashita K; Oguchi T; Aizawa T
    Acta Diabetol; 2019 May; 56(5):525-529. PubMed ID: 30707298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular and renal burdens of prediabetes in the USA: analysis of data from serial cross-sectional surveys, 1988-2014.
    Ali MK; Bullard KM; Saydah S; Imperatore G; Gregg EW
    Lancet Diabetes Endocrinol; 2018 May; 6(5):392-403. PubMed ID: 29500121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fasting plasma glucose and variation in cardiometabolic risk factors in people with high-risk HbA1c-defined prediabetes: A cross-sectional multiethnic study.
    Srivanichakorn W; Godsland IF; Thomson H; Misra S; Phisalprapa P; Charatcharoenwitthaya P; Pramyothin P; Washirasaksiri C; Snehalatha C; Ramachandran A; Alberti KGMM; Johnston DG; Oliver NS
    Diabetes Res Clin Pract; 2017 Dec; 134():183-190. PubMed ID: 29074126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applicability of a combination of hemoglobin A(1c) and fasting plasma glucose in population-based prediabetes screening.
    Okosun IS; Davis-Smith M; Paul Seale J; Ngulefac J
    J Diabetes; 2012 Dec; 4(4):407-16. PubMed ID: 22268513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of progression to diabetes from prediabetes defined by HbA1c or fasting plasma glucose criteria in Koreans.
    Kim CH; Kim HK; Kim EH; Bae SJ; Choe J; Park JY
    Diabetes Res Clin Pract; 2016 Aug; 118():105-11. PubMed ID: 27368062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.